Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03558022 · ClinicalTrials.gov registry record · NA
Vascular Responses to Sympathetic Activation and Altered Shear Rate: The Impact of Hypertension and Sodium Intake
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT03558022 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 34 participants.
The verdict
NCT03558022, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The aim of this study is to determine if alterations in sodium intake alter peripheral vascular function and exercise tolerance in young individuals.
Interventions
- DIETARY_SUPPLEMENT Salt Pills
- DIETARY_SUPPLEMENT Placebo Pills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2018-05-15 |
| Est. Completion | 2021-11-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03558022
The ClinicalTrials.gov registry entry for NCT03558022 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Salt Pills is the first listed.
NCT03558022 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03558022 about?
NCT03558022 is a clinical study titled "Vascular Responses to Sympathetic Activation and Altered Shear Rate: The Impact of Hypertension and Sodium Intake". The aim of this study is to determine if alterations in sodium intake alter peripheral vascular function and exercise tolerance in young individuals.
What is the current status of trial NCT03558022?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2018-05-15. Estimated completion is 2021-11-05.
What interventions are being tested in trial NCT03558022?
The interventions under investigation include: Salt Pills (DIETARY_SUPPLEMENT), Placebo Pills (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03558022?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.